Adlai Nortye (ANL) Cash & Current Investments (2022 - 2025)

Adlai Nortye (ANL) reported Cash & Current Investments of $8.1 million for Q4 2025, down 86.77% year-over-year from $60.9 million in Q4 2024, and down 86.77% on a QoQ basis from $60.9 million in Q2 2025.

Adlai Nortye (ANL) has 4 years of Cash & Current Investments data on file, last reported at $8.1 million in Q4 2025.

  • Quarterly Cash & Current Investments fell 86.77% year-over-year to $8.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.1 million (down 86.77% YoY) and the FY2025 annual result came in at $8.1 million, down 86.77% from the prior year.
  • Cash & Current Investments eased to $8.1 million in Q4 2025 per ANL's latest filing, from $60.9 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $98.5 million in Q4 2023 and bottomed at $8.1 million in Q4 2025.
  • The 4-year median for Cash & Current Investments is $62.5 million (2022), against an average of $65.1 million.
  • The widest annual swing landed in 2023, when Cash & Current Investments surged 53.79%; it then tumbled 86.77% in 2025.
  • Tracing ANL's Cash & Current Investments over 4 years: stood at $64.0 million in 2022, then surged by 53.79% to $98.5 million in 2023, then slumped by 38.16% to $60.9 million in 2024, then plunged by 86.77% to $8.1 million in 2025.
  • Per Business Quant, the three latest ANL Cash & Current Investments figures stand at $8.1 million (Q4 2025), $60.9 million (Q2 2025), and $60.9 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 2.13 Mn
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 32.30 Mn
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 901.90 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - 61.46 Mn
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 7.25 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 8.75 Bn
8 Evaxion A 65.44 Bn 65.42 Bn - 18.44 Mn
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 3.01 Bn
10 Adlai Nortye 23,840.00 -8.03 Mn - 8.06 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 8.06 Mn
Jun 30, 2025 60.91 Mn
Dec 31, 2024 60.91 Mn
Jun 30, 2024 97.99 Mn
Dec 31, 2023 98.49 Mn
Dec 31, 2022 64.05 Mn